NASDAQ
No price data available for this timeframe.
Axsome Therapeutics, Inc. (AXSM) has a free cash flow growth of -11.20% as of Friday, May 29, 2026. This represents a 97.68% increase compared to its 12-month average of -483.23%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.